Assessing inflammation at Porsolt

The airway inflammation model, induced by the administration of bacterial LPS, is a good example of the versatility of Porsolt’s capabilities in determining the anti-inflammatory effects of test substances. Numerous…

Continue Reading Assessing inflammation at Porsolt

EACR 2022 meeting

Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain. We are presenting 2 posters describing how preclinical models assist with identifying new therapeutic options…

Continue Reading EACR 2022 meeting

Hot off the press !! Again !!

Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T…

Continue Reading Hot off the press !! Again !!

Careers

Porsolt environment Porsolt is an internationally recognized CRO, known for its innovative and quality approaches in assisting clients at all stages of the preclinical development process.  We offer inspiring and…

Continue Reading Careers

SAFETY REGULATORY PACKAGE

SAFETY REGULATORY PACKAGE Porsolt’s broad expertise and years of preclinical pharmacology experience makes us the ideal partner to conduct your GLP Safety Pharmacology experiments. Porsolt offers safety studies in both…

Continue Reading SAFETY REGULATORY PACKAGE